FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer November 9, 2018December 14, 2022 Arthur N. Brodsky, PhD
Cemiplimab Becomes First Treatment Approved for CSCC September 29, 2018December 14, 2022 Arthur N. Brodsky, PhD
First Immunotherapy Approved for Patients with Small Cell Lung Cancer August 20, 2018December 14, 2022 Arthur N. Brodsky, PhD
First Checkpoint Immunotherapy Approved for Advanced Cervical Cancer June 13, 2018December 14, 2022 Arthur N. Brodsky, PhD